{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:18:10Z","timestamp":1788049090350,"version":"build-2784847793"},"reference-count":41,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"id":[{"id":"https:\/\/ror.org\/002yp7f20","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/028wp3y58","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["vworld"],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:p>Background and Aim: Cannabidiol (CBD) is increasingly administered via electronic vaporizers because inhalation enables rapid pulmonary absorption and bypasses first-pass hepatic metabolism. However, the respiratory consequences of repeated exposure to purified CBD vapor remain insufficiently characterized. This study investigated the systemic and pulmonary effects of repeated whole-body inhalation of purified CBD vapor in Sprague\u2013Dawley rats, with emphasis on the temporal progression of pulmonary histopathological changes.\n\nMaterials and Methods: Thirty 9-week-old male Sprague\u2013Dawley rats were randomly allocated to five groups (n = 6\/group): saline-exposed control and CBD vapor exposure for 15, 30, 60, or 90 consecutive days. Approximately 100 mg of purified CBD isolate was loaded into an electronic vaporization device for each exposure session, and individual rats underwent whole-body exposure for 5 min\/day under standardized chamber conditions. Clinical status, body weight, and rectal temperature were monitored. Hematological, biochemical, and electrolyte parameters were measured at the end of each exposure period. Lung and extrapulmonary tissues were examined histopathologically. Pulmonary lesions were independently evaluated by two blinded veterinary pathologists using a semi-quantitative grading scale.\n\nResults: No mortality, clinically apparent morbidity, abnormal respiratory signs, or significant differences in body weight were observed. Several hematological and biochemical variables differed significantly among groups; however, most post hoc comparisons were nonsignificant, and all values remained within physiological reference intervals. No histopathological abnormalities were detected in the liver, gastrointestinal tract, kidneys, or brain. In contrast, repeated CBD vapor exposure produced progressive pulmonary inflammatory and vascular alterations. Interstitial pneumonia and bronchus-associated lymphoid tissue hyperplasia were evident from 15 days, whereas perivascular eosinophilic cuffing and pulmonary arterial smooth muscle hypertrophy increased with exposure duration. The most severe lesions occurred after 60 and 90 days and included marked interstitial inflammation, dense eosinophilic perivascular infiltrates, hemorrhagic foci, and advanced arterial remodeling.\n\nConclusion: Repeated whole-body inhalation of purified CBD vapor was associated with progressive, localized pulmonary inflammatory and vascular changes despite the absence of clinically meaningful systemic toxicity. These findings support further studies incorporating aerosol characterization, inhaled dosimetry, pulmonary function testing, mechanistic biomarkers, recovery assessment, and clinically relevant vaping formulations.\n\nKeywords: cannabidiol, inhalation toxicology, pulmonary inflammation, pulmonary vascular remodeling, rat model, respiratory safety, Sprague\u2013Dawley rats, whole-body inhalation.<\/jats:p>","DOI":"10.14202\/vetworld.2026.3701-3715","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:09:07Z","timestamp":1788048547000},"page":"3701","update-policy":"https:\/\/doi.org\/10.14202\/vetworld.2022.policies","source":"Crossref","is-referenced-by-count":0,"title":["Repeated whole-body inhalation of cannabidiol vapor induces progressive pulmonary inflammatory and vascular remodeling without systemic toxicity in Sprague\u2013Dawley rats"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5148-4696","authenticated-orcid":false,"given":"Chutchai","family":"Piewbang","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/028wp3y58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chulalongkorn University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-1409","authenticated-orcid":false,"given":"Sitthiphon","family":"Bunman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002yp7f20","id-type":"ROR","asserted-by":"publisher"}],"name":"Thammasat University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-8992","authenticated-orcid":false,"given":"Tanit","family":"Kasantikul","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05hs6h993","id-type":"ROR","asserted-by":"publisher"}],"name":"Michigan State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-4428","authenticated-orcid":false,"given":"Sombat","family":"Muengtaweepongsa","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Family Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7099-0183","authenticated-orcid":false,"given":"Prakasit","family":"Wannapaschaiyong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01znkr924","id-type":"ROR","asserted-by":"publisher"}],"name":"Mahidol University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4888-2677","authenticated-orcid":false,"given":"Somporn","family":"Techangamsuwan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/028wp3y58","id-type":"ROR","asserted-by":"publisher"}],"name":"Chulalongkorn University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5308","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.\tRock EM, Parker LA. Constituents of Cannabis sativa. Adv Exp Med Biol. 2021;1264:1-13.","DOI":"10.1007\/978-3-030-57369-0_1"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.\tRossi GN, Os\u00f3rio FL, Morgan CJA, Crippa JAS, Bouso JC, Rocha JM, et al. The effects of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: a systematic review of randomized controlled trials. Neurosci Biobehav Rev. 2020;118:236-46.","DOI":"10.1016\/j.neubiorev.2020.07.034"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tTih\u0103uan BM, Onisei T, Slootweg W, Gun\u0103 D, Iliescu C, Chifiriuc MC. Cannabidiol\u2014a friend or a foe? Eur J Pharm Sci. 2025;208:107036.","DOI":"10.1016\/j.ejps.2025.107036"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tJones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, et al. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. J Pharmacol Exp Ther. 2010;332(2):569-77.","DOI":"10.1124\/jpet.109.159145"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.\tSingh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, et al. Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review. Behav Neurol. 2023;2023:8825358.","DOI":"10.1155\/2023\/8825358"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tBidwell LC, Martin-Willett R, Karoly HC. Advancing the science on cannabis concentrates and behavioural health. Drug Alcohol Rev. 2021;40(6):900-13.","DOI":"10.1111\/dar.13281"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tJavadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, et al. Effects of \u03949-THC and cannabidiol vapor inhalation in male and female rats. Psychopharmacology (Berl). 2018;235(9):2541-57.","DOI":"10.1007\/s00213-018-4946-0"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.\tBoehnke KF, Gagnier JJ, Matallana L, Williams DA. Cannabidiol product dosing and decision-making in a national survey of individuals with fibromyalgia. J Pain. 2022;23(1):45-54.","DOI":"10.1016\/j.jpain.2021.06.007"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.\tDevinsky O, Kraft K, Rusch L, Fein M, Leone-Bay A. Improved bioavailability with dry powder cannabidiol inhalation: a phase 1 clinical study. J Pharm Sci. 2021;110(12):3946-52.","DOI":"10.1016\/j.xphs.2021.08.012"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tBhat TA, Kalathil SG, Goniewicz ML, Hutson A, Thanavala Y. Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine. Thorax. 2023;78(9):922-32.","DOI":"10.1136\/thorax-2022-218743"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tHu Z, Qin Z, Xie J, Qu Y, Yin L. Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects. Biomed Pharmacother. 2024;176:116271.","DOI":"10.1016\/j.biopha.2024.116271"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tTallon MJ, Child R. Subchronic oral toxicity assessment of a cannabis extract. Regul Toxicol Pharmacol. 2023;144:105496.","DOI":"10.1016\/j.yrtph.2023.105496"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tArnold JC, McCartney D, Suraev A, McGregor IS. The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence. Clin Transl Sci. 2023;16(1):10-30.","DOI":"10.1111\/cts.13425"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tRibeiro A, Almeida VI, Costola-de-Souza C, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, et al. Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury. Immunopharmacol Immunotoxicol. 2015;37(1):35-41.","DOI":"10.3109\/08923973.2014.976794"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.\tWoo W, Tran LN, Tian L, Canchola A, Lin Y-H. Dynamic chemistry and toxicity of e-cigarette aerosols and their product waste. Chem Res Toxicol. 2026;39(3):253-66.","DOI":"10.1021\/acs.chemrestox.5c00408"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tBeigh S, Jawed A, Dar SA. Beyond nicotine: toxicological insights into metals, nanoparticles, and flavoring agents in e-cigarette aerosols. J Appl Toxicol. 2026.","DOI":"10.1002\/jat.70310"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.\tAtalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants (Basel). 2019;9(1).","DOI":"10.3390\/antiox9010021"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tVuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, et al. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. Eur J Pharmacol. 2019;843:251-9.","DOI":"10.1016\/j.ejphar.2018.11.029"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.\tPark JA, Crotty Alexander LE, Christiani DC. Vaping and lung inflammation and injury. Annu Rev Physiol. 2022;84:611-29.","DOI":"10.1146\/annurev-physiol-061121-040014"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.\tMeyer P, Langos M, Brenneisen R. Human pharmacokinetics and adverse effects of pulmonary and intravenous THC-CBD formulations. Med Cannabis Cannabinoids. 2018;1(1):36-43.","DOI":"10.1159\/000489034"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.\tOdum AL, Willis-Moore ME, Callister KT, Haynes JM, Frye CCJ, Scribner LN, et al. The rodent electronic nicotine delivery system: apparatus for voluntary nose-only e-cigarette aerosol inhalation. bioRxiv. 2025.","DOI":"10.1101\/2024.12.21.629932"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.\tGorguner M, Akgun M. Acute inhalation injury. Eurasian J Med. 2010;42(1):28-35.","DOI":"10.5152\/eajm.2010.09"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.\tSwenson K. Beyond the hype: a comprehensive exploration of CBD\u2019s biological impacts and mechanisms of action. J Cannabis Res. 2025;7(1):24.","DOI":"10.1186\/s42238-025-00274-y"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.\tLewandowska AA, Rybacki C, Graczyk M, Wa\u015bniowska D, Ko\u0142odziej M. Is there a place for cannabinoids in asthma treatment? Int J Mol Sci. 2025;26(7).","DOI":"10.3390\/ijms26073328"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25.\tAnil SM, Peeri H, Koltai H. Medical cannabis activity against inflammation: active compounds and modes of action. Front Pharmacol. 2022;13:908198.","DOI":"10.3389\/fphar.2022.908198"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.\tMlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci. 2020;21(22).","DOI":"10.3390\/ijms21228870"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.\tJeffrey M, Bartholdson Scott J, Mazumdar S, White RJ, Higginson E, Maes M, et al. Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes. Nat Commun. 2026;17(1):5312.","DOI":"10.1038\/s41467-026-74190-x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.\tLo LA, Christiansen AL, Strickland JC, Pistawka CA, Eadie L, Vandrey R, et al. Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC). Neuropsychopharmacology. 2024;49(9):1425-36.","DOI":"10.1038\/s41386-024-01847-w"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29.\tClapp PW, Jaspers I. Electronic cigarettes: their constituents and potential links to asthma. Curr Allergy Asthma Rep. 2017;17(11):79.","DOI":"10.1007\/s11882-017-0747-5"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.\tTraboulsi H, Cherian M, Abou Rjeili M, Preteroti M, Bourbeau J, Smith BM, et al. Inhalation toxicology of vaping products and implications for pulmonary health. Int J Mol Sci. 2020;21(10).","DOI":"10.3390\/ijms21103495"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31.\tMa T, Wang X, Li L, Sun B, Zhu Y, Xia T. Electronic cigarette aerosols induce oxidative stress-dependent cell death and NF-\u03baB mediated acute lung inflammation in mice. Arch Toxicol. 2021;95(1):195-205.","DOI":"10.1007\/s00204-020-02920-1"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.\tMuthumalage T, Lucas JH, Wang Q, Lamb T, McGraw MD, Rahman I. Pulmonary toxicity and inflammatory response of e-cigarette vape cartridges containing medium-chain triglycerides oil and vitamin E acetate: implications in the pathogenesis of EVALI. Toxics. 2020;8(3).","DOI":"10.3390\/toxics8030046"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33.\tBeard JM, Sayes CM. An examination of the methods and variables used in experimental design that impact the toxicological outcomes of e-cigarettes. Food Chem Toxicol. 2024;193:114999.","DOI":"10.1016\/j.fct.2024.114999"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.\tYang X, Che W, Zhang L, Zhang H, Chen X. Chronic airway inflammatory diseases and e-cigarette use: a review of health risks and mechanisms. Eur J Med Res. 2025;30(1):223.","DOI":"10.1186\/s40001-025-02492-9"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.\tLupo G, Anfuso CD, Smecca G, Cosentino A, Agafonova A, Prinzi C, et al. Assessing the impact of e-cigarettes on human barrier systems: a systematic review. Transl Res. 2025;277:39-63.","DOI":"10.1016\/j.trsl.2025.01.001"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.\tRaduka A, Gao N, Chatburn RL, Rezaee F. Electronic cigarette exposure disrupts airway epithelial barrier function and exacerbates viral infection. Am J Physiol Lung Cell Mol Physiol. 2023;325(5):L580-L93.","DOI":"10.1152\/ajplung.00135.2023"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37.\tTapak M, Sadeghi S, Ghazanfari T, Mosaffa N. Chemical exposure and alveolar macrophages responses: \u2018the role of pulmonary defense mechanism in inhalation injuries\u2019. BMJ Open Respir Res. 2023;10(1).","DOI":"10.1136\/bmjresp-2022-001589"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.\tHiraiwa K, van Eeden SF. Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants. Mediators Inflamm. 2013;2013:619523.","DOI":"10.1155\/2013\/619523"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39.\tTamagawa E, Bai N, Morimoto K, Gray C, Mui T, Yatera K, et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol. 2008;295(1):L79-85.","DOI":"10.1152\/ajplung.00048.2007"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40.\tNagato AC, Machado-Junior PA, Valenca SS, Russo RC, Bezerra FS. Experimental models of acute lung injury to study inflammation and pathophysiology: a narrative review. Antioxidants (Basel). 2026;15(1).","DOI":"10.3390\/antiox15010063"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.\tHelyes Z, Kem\u00e9ny \u00c1, Csek\u0151 K, Sz\u0151ke \u00c9, Elekes K, Mester M, et al. Marijuana smoke induces severe pulmonary hyperresponsiveness, inflammation, and emphysema in a predictive mouse model not via CB1 receptor activation. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L267-L77.","DOI":"10.1152\/ajplung.00354.2016"}],"container-title":["Veterinary World"],"original-title":[],"link":[{"URL":"https:\/\/veterinaryworld.org\/Vol.19\/August-2026\/24.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:09:13Z","timestamp":1788048553000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryworld.org\/Vol.19\/August-2026\/24.php"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":41,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2026.3701-3715","relation":{},"ISSN":["0972-8988","2231-0916"],"issn-type":[{"value":"0972-8988","type":"print"},{"value":"2231-0916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"24"}}